Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Buchang Pharmaceutical is a major subsidiary of Shandong Buchang Pharmaceuticals, one of China's leading private pharmaceutical enterprises. Based in Meihekou, Jilin Province, the company specializes in the research, development, and large-scale manufacturing of Traditional Chinese Medicine (TCM) and modern chemical drugs. Its core therapeutic focus includes cardiovascular and cerebrovascular health, respiratory conditions, and gynecological disorders. The company operates advanced, GMP-certified production facilities for various dosage forms, including capsules, tablets, and injections. As part of the broader Buchang Pharma group, Jilin Buchang is increasingly involved in the group's strategic shift toward high-tech biologics and innovative small molecules while maintaining its leadership in the TCM market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Buchang Pharmaceutical.